MedPath
NMPA Approval

Ligustrazine Hydrochloride Injection

国药准字H22025223

March 15, 2024

Drug Information

盐酸川芎嗪注射液

注射剂

2ml:40mg

化学药品

March 15, 2024

Company Information

Applicant Company

中山火炬开发区国家健康基地内健康路17号

Manufacturing Company

中山火炬开发区国家健康基地内健康路17号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸川芎嗪注射液 - NMPA 批准文号 | MedPath